Skip to main content
Clinical Trials/NL-OMON34435
NL-OMON34435
Completed
Not Applicable

Thrombocyte function and the relationship to blood loss and need for transfusion during coronary artery bypass surgery. - Thrombocyte function and transfusion during coronary bypass chirurgie.

Catharina-ziekenhuis0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thrombocyte dysfunction during cardiac surgery
Sponsor
Catharina-ziekenhuis
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Elective CABG\-procedure with use of extracorporale circulation
  • Group 1: Minimum of 5 days use of clopidogrel and aspirin until day of procedure.
  • Group 2: Minimum of 5 days use of aspirin until the day of procedure, but no clopidogrel use for at least 5 days prior to the procedure.

Exclusion Criteria

  • Use of coumarines or (low molecular weight) heparin
  • Clinical or laboratory signs of hemorrhagic diathesis
  • Cardiac failure
  • Renal insufficiency or dialysis
  • Liver failure
  • Chronic alcoholism
  • Age \<18 years

Outcomes

Primary Outcomes

Not specified

Similar Trials